Skip to main content

Bank of New York Mellon Corp

Bank

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in HALO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$63,585,700
-$1,098,277 QoQ
Shares Held
983,842
+2.4% QoQ
Ownership
0.829%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 93.02489627399521.ToString("F0")% Shared 0.02408923384039307.ToString("F0")% None 6.951014492164393.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. HALO ranks #14 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $63,585,700 983,842
2025-12-31 $64,683,977 961,129
2025-09-30 $77,229,946 1,053,040
2025-06-30 $46,973,220 902,984
2025-03-31 $62,661,414 982,000
2024-12-31 $46,895,388 980,870
2024-09-30 $56,613,674 989,058
2024-06-30 $61,820,400 1,180,680
2024-03-31 $49,393,040 1,214,185
2023-12-31 $47,806,866 1,293,476
2023-09-30 $49,727,762 1,301,774
2023-06-30 $47,995,960 1,330,634
2023-03-31 $53,071,531 1,389,671
2022-12-31 $81,843,247 1,438,370
2022-09-30 $60,151,803 1,521,290
2022-06-30 $67,772,144 1,540,276
2022-03-31 $60,949,118 1,528,313
2021-12-31 $61,934,090 1,540,266
2021-09-30 $63,888,951 1,570,525
2021-06-30 $67,138,090 1,478,487
2021-03-31 $60,200,230 1,443,997
2020-09-30 $18,896,552 719,047
2020-06-30 $18,665,334 696,208
2020-03-31 $11,205,825 622,892